Thomas Stephen Basil bought CLYM
August 7, 2025 · Form 4 insider transaction
Thomas Stephen Basil bought 100,375 shares of Climb Bio Inc at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
100,375
Price
$0.00
Total value
N/A
InsiderThomas Stephen Basil
RoleDirector
CompanyClimb Bio Inc (CLYM)
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateAugust 7, 2025
Filing dateAugust 11, 2025
Shares owned after304,657
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On June 27, 2024, the reporting person was granted restricted stock units ("RSUs") to acquire a total of 100,375 shares of common stock that vested based on the achievement of certain performance-based milestones and subject to continuous service. On August 7, 2025, the milestones were deemed to be achieved, resulting in the vesting of the RSUs as to all 100,375 shares.